BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 14624219)

  • 1. Misoprostol and pregnancy: ever-increasing indications of effective usage.
    Lokugamage AU; Refaey HE; Rodeck CH
    Curr Opin Obstet Gynecol; 2003 Dec; 15(6):513-8. PubMed ID: 14624219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy and safety of misoprostol in obstetrics].
    Capilla Montes C; Bermejo Vicedo T
    Farm Hosp; 2005; 29(3):177-84. PubMed ID: 16013944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Misoprostol and pregnancy.
    Goldberg AB; Greenberg MB; Darney PD
    N Engl J Med; 2001 Jan; 344(1):38-47. PubMed ID: 11136959
    [No Abstract]   [Full Text] [Related]  

  • 4. WHO recommendations for misoprostol use for obstetric and gynecologic indications.
    Tang J; Kapp N; Dragoman M; de Souza JP
    Int J Gynaecol Obstet; 2013 May; 121(2):186-9. PubMed ID: 23433680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Misoprostol off label essential for women's health].
    Danielsson KG
    Lakartidningen; 2013 Nov 13-19; 110(46):2045-6. PubMed ID: 24380157
    [No Abstract]   [Full Text] [Related]  

  • 6. [Misoprostol--a new prostaglandin in obstetrical practice].
    Katsulov A; Todorova Ts
    Akush Ginekol (Sofiia); 1998; 37(2):59-66. PubMed ID: 9859543
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of misoprostol in gynecology and obstetrics].
    Béchard de Spirlet M
    Gynecol Obstet Fertil; 2002 Apr; 30(4):317-24. PubMed ID: 12043508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The combination of mifepristone and misoprostol for the termination of pregnancy.
    ;
    Int J Gynaecol Obstet; 2011 Oct; 115(1):1-4. PubMed ID: 21872858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of misoprostol for induction of labor in case of fetal death or termination of pregnancy during second or third trimester of pregnancy: Efficiency, dosage, route of administration, side effects, use in case of uterine scar].
    Clouqueur E; Coulon C; Vaast P; Chauvet A; Deruelle P; Subtil D; Houfflin-Debarge V
    J Gynecol Obstet Biol Reprod (Paris); 2014 Feb; 43(2):146-61. PubMed ID: 24461423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of misoprostol in pregnancy.
    Hale RW; Zinberg S
    N Engl J Med; 2001 Jan; 344(1):59-60. PubMed ID: 11136964
    [No Abstract]   [Full Text] [Related]  

  • 11. Misoprostol: a quarter century of use, abuse, and creative misuse.
    Chong YS; Su LL; Arulkumaran S
    Obstet Gynecol Surv; 2004 Feb; 59(2):128-40. PubMed ID: 14752301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Misoprostol in second and early third trimester for termination of pregnancies with fetal anomalies.
    Mendilcioglu I; Simsek M; Seker PE; Erbay O; Zorlu CG; Trak B
    Int J Gynaecol Obstet; 2002 Nov; 79(2):131-5. PubMed ID: 12427397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Misoprostol in gynecology and obstetrics].
    Halmesmäki E; Nuutila M
    Duodecim; 1998; 114(14):1422-4. PubMed ID: 11552252
    [No Abstract]   [Full Text] [Related]  

  • 14. The use of misoprostol in termination of second-trimester pregnancy.
    Lin CJ; Chien SC; Chen CP
    Taiwan J Obstet Gynecol; 2011 Sep; 50(3):275-82. PubMed ID: 22030039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Status and expertise of off-label use of misoprostol in obstetrics and gynecology in France: study by CNGOF (short text)].
    Marret H; Simon E; Beucher G; Dreyfus M; Gaudineau A; Vayssière C; Lesavre M; Pluchon M; Winer N; Fernandez H; Aubert J; Bejan-Angoulvant T; Jonville-Bera AP; Clouqueur E; Houfflin-Debarge V; Garrigue A; Pierre F;
    J Gynecol Obstet Biol Reprod (Paris); 2014 Feb; 43(2):107-13. PubMed ID: 24438770
    [No Abstract]   [Full Text] [Related]  

  • 16. Misoprostol for the prevention and treatment of postpartum hemorrhage.
    Sheldon WR; Blum J; Durocher J; Winikoff B
    Expert Opin Investig Drugs; 2012 Feb; 21(2):235-50. PubMed ID: 22233426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Manufacturer's warning regarding unapproved uses of misoprostol.
    Friedman MA
    N Engl J Med; 2001 Jan; 344(1):61. PubMed ID: 11187113
    [No Abstract]   [Full Text] [Related]  

  • 18. Association of intravenous oxytocin to vaginal misoprostol for mid trimester labor induction.
    Hidar S; Jerbi M; Khaïri H
    Am J Obstet Gynecol; 2006 Jul; 195(1):332-3; author reply 333-4. PubMed ID: 16813766
    [No Abstract]   [Full Text] [Related]  

  • 19. Physicians' approaches to post-abortion care in Manila, Philippines.
    Cansino C; Melgar JL; Burke A
    Int J Gynaecol Obstet; 2010 Jun; 109(3):216-8. PubMed ID: 20176351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Misoprostol-only versus mifepristone plus misoprostol in induction of labor following intrauterine fetal death.
    Väyrynen W; Heikinheimo O; Nuutila M
    Acta Obstet Gynecol Scand; 2007; 86(6):701-5. PubMed ID: 17520402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.